Effect of constructing doctor-pharmacist joint pharmacy clinic for outpatients on the comprehensive management of type 2 diabetes mellitus: a pilot RCT

Background Comprehensive management of type 2 diabetes mellitus (T2DM) patients has a low control rate, and there is a lack of prospective studies involving clinical pharmacists in outpatient management of patients with T2DM. This study was designed to investigate the effectiveness of pharmacists participating in the comprehensive management of T2DM patients in the form of building doctor-pharmacist joint pharmacy clinic in the National Metabolic Management Center (MMC). Methods A total of 204 patients with type 2 diabetes mellitus were enrolled and randomly divided into control group and intervention group. During the 3-month study period, both groups received standardized MMC diagnosis and treatment, and clinical pharmacists provided pharmaceutical care for the intervention group. Observation indicators include drug compliance, fasting blood glucose (FPG), glycosylated hemoglobin (HbA1c), blood pressure, blood lipid, and other comprehensive management indicators. Results The baseline characteristics of the two groups were similar, and there was no significant difference (p > 0.05). After 3 months of follow-up, drug compliance, HbA1c, FPG, low-density cholesterol (LDL-c), and diastolic blood pressure in the intervention group were more significantly improved compared with those in the control group (p